American Century Companies’s Health Catalyst HCAT Stock Holding History

American Century Companies's HCAT Position: Q1 2026 in Review

American Century Companies reduced its Health Catalyst (HCAT) stake by 15% in Q1 2026, selling an estimated $36.4K and leaving 112,810 shares worth $143K. The position accounts for ﹤0.01% of the portfolio, ranked #2748.

American Century Companies first reported a position in HCAT in Q3 2019 and has held it in 27 quarters since. The position peaked at $59.2M in Q2 2021. 130 funds tracked by Wall St. Rank hold HCAT as of Q1 2026.

• American Century Companies held 112,810 shares of Health Catalyst worth $143K as of Q1 2026.
• American Century Companies sold 19,327 Health Catalyst shares in Q1 2026, an estimated $36.4K.
• Health Catalyst made up ﹤0.01% of American Century Companies's portfolio in Q1 2026, its #2748 holding.
• American Century Companies first reported a position in Health Catalyst in Q3 2019 and has held it in 27 quarters since.
• American Century Companies's Health Catalyst position peaked at $59.2M in Q2 2021.
• 130 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2026.

Based on American Century Companies's 13F filing for Q1 2026, filed 15 May 2026.